Previous 10 | Next 10 |
Dr. Reddy’s Laboratories (RDY) joins forces with Biotechnology Industry Research Assistance Council ((BIRAC)), Department of Biotechnology ((DBT)), Government of India, for advisory support on clinical trials of Sputnik V vaccine in India. The partnership will allow Dr. Reddy’s ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on clinical trials of Sputnik V vaccine in...
Dr. Reddy's Laboratories Limited (RDY) Q2 2021 Earnings Conference Call October 28, 2020 8:00 AM ET Company Participants Amit Agarwal - Head-Investor Relations Erez Israeli - Chief Executive Officer Saumen Chakraborty - Chief Financial Officer Conference Call Participants Prakash Agarwal - Ax...
Dr. Reddy's ([[RDY]] -3.8%) FQ2 results:Revenues: 666M (+2.0%) vs consensus of $637.37M.Revenue by segment (₹) : Pharmaceutical Services and Active Ingredients: 8,505M (+20%); Global Generics: 39,841M (+21%); Proprietary Products & Others: 621M (+92%);...
Dr. Reddy’s Laboratories (RDY) announces that Parag Agarwal will be joining as Chief Financial Officer ((CFO))(Designate) on November 2, 2020.The Board of Directors has approved his appointment as a CFO ((KMP)) of the Company effective December 1, 2020. In a career spanning over 33 yea...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that Parag Agarwal will be joining the Company as Chief Financial Officer (Designate) on November 2, 2020. The Board of Directors at their meeting held today, has approved his appointment as a Ch...
The best sectors to focus your attention on now. The highest-rated stocks worth adding to your watch list. Why high-volatility ahead of elections could create a great buy opportunity. For further details see: If Stocks Tumble On Election Worries, Here Are The Top Stocks ...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced its consolidated financial results for the quarter and the half year ended September 30, 2020. The information mentioned in this release is on the basis of consolidated financial statements und...
The U.S. Food and Drug Administration approves the re-launch of Dr. Reddy’s Laboratories's (RDY) over-the-counter ((OTC)) Famotidine Tablets USP, 10 mg and 20 mg, the store-brand equivalent of Pepcid AC (a registered trademark of Johnson & Johnson), in the US market.Dr. R...
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the re-launch of over-the-counter (OTC) Famotidine Tablets USP, 10 mg and 20 mg, the store-brand equivalent...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...